Shares of pharmaceutical major Cipla zoomed nearly 9 percent in early trade on July 27 after the company's earnings for the April-June period surpassed the Street's expectations. Several brokerages also raised their price targets for the stock as they cheered for the company's solid numbers for the quarter under review.